Valeant Pharmaceuticals International, Inc. (NYSE: VRX and TSX: VRX) announced today that Valeant has signed an agreement to acquire certain assets from Gerot Lannach, a branded generics pharmaceutical company based in Austria.
Valeant Pharmaceuticals International, Inc. (NYSE: VRX and TSX: VRX) announced today that Valeant has signed an agreement to acquire certain assets from Gerot Lannach, a branded generics pharmaceutical company based in Austria.
Ready to take your business to the next level? Our team of experts are here to provide the strategic advice and tailored solutions you need to excel.